Molecular signatures of G-protein-coupled receptors

Nature

Volumn 494, Issue 7436, 2013, Pages 185-194

  Venkatakrishnan, A J ^a   Deupi, Xavier ^b   Lebon, Guillaume ^a,c,d   Tate, Christopher G ^a   Schertler, Gebhard F ^b,e   Madan Babu, M ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

^c INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^d UNIV MONTPELLIER   (France)

^e ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

DISEASE TREATMENT; MEDICINE; MEMBRANE; MOLECULAR ANALYSIS; PHYSIOLOGICAL RESPONSE; PROTEIN;

COVALENT BOND; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; HUMAN; LIGAND BINDING; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW;

ANIMALS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HUMANS; LIGANDS; PROTEIN CONFORMATION; PROTEIN FOLDING; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84873685831     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11896     Document Type: Review

References (100)

1. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G. & Schioth, H. B. The G-proteincoupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256-1272 (2003).
2. Tate, C. G., Schertler, G. F. & Engineering, G. Protein-coupled receptors to facilitate their structure determination. Curr. Opin. Struct. Biol. 19, 386-395 (2009).
3. Cherezov, V. et al. High-resolution crystal structure of an engineered human b2-adrenergic G protein-coupled receptor. Science 318, 1258-1265 (2007).
4. Rosenbaum, D. M. et al. GPCR engineering yields high-resolution structural insights into b2-adrenergic receptor function. Science 318, 1266-1273 (2007).
5. Thompson, A. A. et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 485, 395-399 (2012).
6. Rasmussen, S. G. et al. Crystal structure of the human b2 adrenergic G-proteincoupled receptor. Nature 450, 383-387 (2007).
7. Hino, T. et al. G-protein-coupled receptor inactivation by an allosteric inverseagonist antibody. Nature 482, 237-240 (2012).
8. Rasmussen, S. G. et al. Structure of a nanobody-stabilized active state of the b2 adrenoceptor. Nature 469, 175-180 (2011).
9. Rasmussen, S. G. et al. Crystal structure of the b2 adrenergic receptor-Gs protein complex. Nature 477, 549-555 (2011).
10. Warne, T. et al. Structure of a b1-adrenergic G-protein-coupled receptor. Nature 454, 486-491 (2008).
11. Lebon, G. et al.Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 474, 521-525 (2011).
12. Doré, A. S. et al. Structure of the adenosine A2A receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure 19, 1283-1293 (2011).
13. Standfuss, J. et al. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 471, 656-660 (2011).
14. Deupi, X. et al. Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II. Proc. Natl Acad. Sci. USA 109, 119-124 (2012).
15. Caffrey, M. Crystallizing membrane proteins for structure determination: use of lipidic mesophases. Annu. Rev. Biophys. 38, 29-51 (2009).
16. Chae, P. S. et al. Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nature Methods 7, 1003-1008 (2010).
17. Moukhametzianov, R. et al. Protein crystallography with a micrometre-sized synchrotron-radiation beam. Acta Crystallogr. D 64, 158-166 (2008).
18. Palczewski, K. et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745 (2000).
19. Murakami, M. & Kouyama, T. Crystal structure of squid rhodopsin. Nature 453, 363-367 (2008).
20. Haga, K. et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482, 547-551 (2012).
21. Kruse, A. C. et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482, 552-556 (2012).
22. Shimamura, T. et al. Structure of the humanhistamineH1 receptor complex with doxepin. Nature 475, 65-70 (2011).
23. Chien, E. Y. et al. Structure of the humandopamineD3receptor in complex with a D2/D3 selective antagonist. Science 330, 1091-1095 (2010).
24. Jaakola, V. P. et al. The 2.6 angstromcrystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211-1217 (2008).
25. Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071 (2010).
26. Wu, H. et al. Structure of the human k-opioid receptor in complex with JDtic. Nature 485, 327-332 (2012).
27. Manglik, A. et al. Crystal structure of the m-opioid receptor bound to amorphinan antagonist. Nature (2012).
28. Granier, S. et al. Structure of the d-opioid receptor bound to naltrindole. Nature 485, 400-404 (2012).
29. White, J. F. et al. Structure of the agonist-bound neurotensin receptor. Nature 490, 508-513 (2012).
30. Zhang, C. et al. High-resolution crystal structure of human protease-activated receptor 1. Nature 492, 387-392 (2012).
31. Hanson, M. A. et al. Crystal structure of a lipidGprotein-coupled receptor. Science 335, 851-855 (2012).
32. Park, S. H. et al. Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature 491, 779-783 (2012).
33. Choe, H. W. et al. Crystal structure of metarhodopsin II. Nature 471, 651-655 (2011).
34. Rosenbaum, D. M. et al. Structure and function of an irreversible agonist-b2 adrenoceptor complex. Nature 469, 236-240 (2011).
35. Warne, T. et al. The structural basis for agonist and partial agonist action on a b1-adrenergic receptor. Nature 469, 241-244 (2011).
36. Warne, T.,Edwards, P. C., Leslie, A. G.&Tate, C. G. Crystal structures of a stabilized b1-adrenoceptor bound to the biased agonists bucindolol and carvedilol. Structure 20, 841-849 (2012).
37. Xu, F. et al. Structure of an agonist-bound human A2A adenosine receptor. Science 332, 322-327 (2011).
38. Scheerer, P. et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455, 497-502 (2008).
39. Lagerström, M. C. & Schiöth, H. B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nature Rev. Drug Discov. 7, 339-357 (2008).
40. Unal, H. & Karnik, S. S. Domain coupling in GPCRs: the engine for induced conformational changes. Trends Pharmacol. Sci. 33, 79-88 (2012).
41. Hurst, D. P. et al. A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor. J. Biol. Chem. 285, 17954-17964 (2010).
42. Dror, R. O. et al. Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc. Natl Acad. Sci. USA 108, 13118-13123 (2011).
43. González, A., Perez-Acle, T., Pardo, L. & Deupi, X. Molecular basis of ligand dissociation in b-adrenergic receptors. PLoS ONE 6, e23815 (2011).
44. Ballesteros, J. A.&Weinstein, H. Integratedmethods for the constructionof threedimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366-428 (1995).
45. Madabushi, S. et al. Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions. J. Biol. Chem. 279, 8126-8132 (2004).
46. Barth, P., Wallner, B. & Baker, D. Prediction of membrane protein structures with complex topologies using limited constraints. Proc. Natl Acad. Sci. USA 106, 1409-1414 (2009).
47. Schlinkmann, K. M. et al. Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations. Proc. Natl Acad. Sci. USA 109, 9810-9815 (2012).
48. Congreve, M., Langmead, C. J., Mason, J. S. & Marshall, F. H. Progress in structure based drug design for G protein-coupled receptors. J. Med. Chem. 54, 4283-4311 (2011).
49. Heitz, F. et al. Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site. Eur. J. Pharmacol. 380, 183-195 (1999).
50. Katritch, V., Cherezov, V. & Stevens, R. C. Diversity and modularity of G proteincoupled receptor structures. Trends Pharmacol. Sci. 33, 17-27 (2011).
51. Valiquette, M., Parent, S., Loisel, T. P. & Bouvier, M. Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human b2-adrenergic receptor. EMBO J. 14, 5542-5549 (1995).
52. Jaakola, V. P., Prilusky, J., Sussman, J. L. & Goldman, A. G. Protein-coupled receptors show unusual patterns of intrinsic unfolding. Protein Eng. Des. Sel. 18, 103-110 (2005).
53. Gsponer, J. & Babu, M. M. The rules of disorder or why disorder rules. Prog. Biophys. Mol. Biol. 99, 94-103 (2009).
54. Babu, M. M., Kriwacki, R. W. & Pappu, R. V. Structural biology. Versatility from protein disorder. Science 337, 1460-1461 (2012).
55. Qin, K., Dong, C., Wu, G. & Lambert, N. A. Inactive-state preassembly of Gqcoupled receptors and Gq heterotrimers. Nature Chem. Biol. 7, 740-747 (2011).
56. Nobles, K. N. et al. Distinct phosphorylation sites on the b2-adrenergic receptor establish a barcode that encodes differential functions of b-arrestin. Sci. Signal. 4, ra51 (2011).
57. Samama, P., Cotecchia, S., Costa, T. & Lefkowitz, R. J. A. Mutation-induced activated state of the b2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268, 4625-4636 (1993).
58. Deupi, X. & Standfuss, J. Structural insights into agonist-induced activation of G-protein-coupled receptors. Curr. Opin. Struct. Biol. 21, 541-551 (2011).
59. Hofmann, K. P. et al. A G protein-coupled receptor at work: the rhodopsin model. Trends Biochem. Sci. 34, 540-552 (2009).
60. Rosenbaum, D. M., Rasmussen, S. G. & Kobilka, B. K. The structure and function of G-protein-coupled receptors. Nature 459, 356-363 (2009).
61. Bockenhauer, S., Furstenberg, A., Yao, X. J., Kobilka, B. K. & Moerner, W. E. Conformational dynamics of single G protein-coupled receptors in solution. J. Phys. Chem. B 115, 13328-13338 (2011).
62. Ghanouni, P. et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the b2 adrenergic receptor. J. Biol. Chem. 276, 24433-24436 (2001).
63. Dror, R. O. et al. Activation mechanism of the b2-adrenergic receptor. Proc. Natl Acad. Sci. USA 108, 18684-18689 (2011).
64. Kahsai, A. W. et al. Multiple ligand-specific conformations of the b2-adrenergic receptor. Nature Chem. Biol. 7, 692-700 (2011).
65. West, G.M. et al. Ligand-dependent perturbationof the conformationalensemble for the GPCR b2 adrenergic receptor revealed by HDX. Structure 19, 1424-1432 (2011).
66. Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H. W.&Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454, 183-187 (2008).
67. Sü el, G. M., Lockless, S. W., Wall, M.A.&Ranganathan, R. Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nature Struct. Biol. 10, 59-69 (2003).
68. Vaidehi, N. & Kenakin, T. The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr. Opin. Pharmacol. 10, 775-781 (2010).
69. Provasi, D., Artacho, M. C., Negri, A., Mobarec, J. C. & Filizola, M. Ligand-induced modulation of the free-energy landscape of G protein-coupled receptors explored by adaptive biasing techniques. PLOS Comput. Biol. 7, e1002193 (2011).
70. Wheatley, M. et al. Lifting the lid on GPCRs: the role of extracellular loops. Br. J. Pharmacol. 165, 1688-1703 (2012).
71. Ahuja, S. et al. Location of the retinal chromophore in the activated state of rhodopsin*. J. Biol. Chem. 284, 10190-10201 (2009).
72. Bokoch, M. P. et al. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 463, 108-112 (2010).
73. Lebon, G., Warne, T. & Tate, C. G. Agonist-bound structures of G protein-coupled receptors. Curr. Opin. Struct. Biol. 22, 482-490 (2012).
74. Deupi, X., Standfuss, J. & Schertler, G. Conserved activation pathways in G-protein-coupled receptors. Biochem. Soc. Trans. 40, 383-388 (2012).
75. Sansuk, K. et al. A structural insight into the reorientation of transmembrane domains 3 and 5 during family a G protein-coupled receptor activation. Mol. Pharmacol. 79, 262-269 (2011).
76. Farrens, D. L., Altenbach, C., Yang, K.,Hubbell, W. L.&Khorana, H. G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768-770 (1996).
77. Sheikh, S. P., Zvyaga, T. A., Lichtarge, O., Sakmar, T. P. & Bourne, H. R. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature 383, 347-350 (1996).
78. Altenbach, C., Kusnetzow, A. K., Ernst, O. P., Hofmann, K. P. & Hubbell, W. L. Highresolution distancemapping in rhodopsin reveals the pattern of helixmovement due to activation. Proc. Natl Acad. Sci. USA 105, 7439-7444 (2008).
79. Ye, S. et al. Tracking G-protein-coupled receptor activation using genetically encoded infrared probes. Nature 464, 1386-1389 (2010).
80. Li, J., Edwards, P. C., Burghammer, M., Villa, C. & Schertler, G. F. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343, 1409-1438 (2004).
81. Moukhametzianov, R. et al. Two distinct conformations of helix 6 observed in antagonist-bound structures of a b1-adrenergic receptor. Proc. Natl Acad. Sci. USA 108, 8228-8232 (2011).
82. Chung, K. Y. et al. Conformational changes in the G protein Gs induced by the b2 adrenergic receptor. Nature 477, 611-615 (2011).
83. Whorton, M. R. et al. A monomeric G protein-coupled receptor isolated in a highdensity lipoprotein particle efficiently activates its G protein. Proc. Natl Acad. Sci. USA 104, 7682-7687 (2007).
84. Rajagopal, S., Rajagopal, K. & Lefkowitz, R. J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nature Rev. Drug Discov. 9, 373-386 (2010).
85. Kenakin, T. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TMreceptors. Trends Pharmacol. Sci. 28, 407-415 (2007).
86. Rosenkilde, M. M., Benned-Jensen, T., Frimurer, T. M.&Schwartz, T. W. The minor binding pocket: a major player in 7TMreceptor activation. Trends Pharmacol. Sci. 31, 567-574 (2010).
87. Liu, J. J., Horst, R., Katritch, V., Stevens, R. C. & Wuthrich, K. Biased signaling pathways in b2-adrenergic receptor characterized by 19F-NMR. Science 335, 1106-1110 (2012).
88. Rahmeh, R. et al. Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy. Proc. Natl Acad. Sci. USA 109, 6733-6738 (2012).
89. Parthier, C., Reedtz-Runge, S., Rudolph, R. & Stubbs, M. T. Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem. Sci. 34, 303-310 (2009).
90. Urwyler, S. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol. Rev. 63, 59-126 (2011).
91. Araç, D. et al. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis. EMBO J. 31, 1364-1378 (2012).
92. Liu, W. et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337, 232-236 (2012).
93. Han, Y., Moreira, I. S., Urizar, E., Weinstein, H. & Javitch, J. A. Allosteric communication between protomers of dopamine class a GPCR dimers modulates activation. Nature Chem. Biol. 5, 688-695 (2009).
94. Congreve, M. et al. Discovery of 1,2,4-triazine derivatives as adenosine A2A antagonists using structure based drug design. J. Med. Chem. 55, 1898-1903 (2012).
95. Heinis, C., Rutherford, T., Freund, S. & Winter, G. Phage-encoded combinatorial chemical libraries based on bicyclic peptides. Nature Chem. Biol. 5, 502-507 (2009).
96. Valant, C., Robert Lane, J., Sexton, P. M. & Christopoulos, A. The best of both worlds? Bitopic orthosteric/allosteric ligands of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 52, 153-178 (2012).
97. Herr, D. R. Potential use of G protein-coupled receptor-blocking monoclonal antibodies as therapeutic agents for cancers. Int. Rev. Cell Mol. Biol. 297, 45-81 (2012).
98. Huber, T. & Sakmar, T. P. Escaping the flatlands: new approaches for studying the dynamic assembly and activation of GPCR signaling complexes. Trends Pharmacol. Sci. 32, 410-419 (2011).
99. Kiel, C. et al. Structural and functional protein network analyses predict novel signaling functions for rhodopsin. Mol. Syst. Biol. 7, 551 (2011).
100. Ahles, A., Rochais, F., Frambach, T., Bunemann, M. & Engelhardt, S. A. Polymorphism-specific "memory" mechanism in the b2-adrenergic receptor. Sci. Signal. 4, ra53 (2011).